Biosimilar Candidates
Immunology, Oncology
Preclinical / Early DevelopmentStrategic Initiative
Key Facts
Indication
Immunology, Oncology
Phase
Preclinical / Early Development
Status
Strategic Initiative
Company
About Towa Pharmaceutical
Towa Pharmaceutical's mission is to ensure a stable supply of high-quality, affordable generic medicines to the Japanese healthcare system. The company has achieved a leading market position through its integrated development and manufacturing platform, becoming one of Japan's most valuable pharmaceutical enterprises. Its strategy centers on deepening its domestic market penetration, expanding into complex generics and biosimilars, and pursuing selective international opportunities to drive sustainable growth.
View full company profileOther Immunology, Oncology Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilar Development | JSC Pharmstandard | Research/Development |
| Biosimilars Pipeline | Jubilant Pharmova | Early Development |
| Biosimilars Program | Aspen Pharmacare | Development & Commercial |
| Biosimilars Development | SPIMACO | Exploratory / Early Development |
| Biosimilar Portfolio | Laboratorios Farmaceuticos Rovi | Clinical Development |